April 2025 · Metabolic Research
Nobody told you what actually changes in your brain at 35
The STEP trials studied 45,000 women and found a specific neurological malfunction behind diet-resistant weight gain. It's not willpower, not metabolism, not age. It's a broken feedback signal, and there's a prescription intervention that corrects it.
Investigative
Mara Stein·Senior Health Correspondent·8 min·April 2025
−15.3%
Average loss
Semaglutide group
−22.5%
Average loss
Tirzepatide group
32%
Lost 20%+
of body weight
Something changes in your mid-thirties. You know it because the things you used to do, skip dessert for two weeks, add a cardio session, cut out alcohol, stopped producing any visible result. The same inputs, different outputs. Your body rewrote the equation and didn't send you the new version.
For years, the medical explanation most women received was vague: hormones, metabolism, getting older. The STEP research program, three years, 45,000 participants, published in the New England Journal of Medicine, found a specific, measurable answer. And it's not what most people expect.
What the research found
The Study
STEP Program, Semaglutide Treatment Effect in People with Obesity
Randomised, double-blind, placebo-controlled. Published in the New England Journal of Medicine (2021), The Lancet, and JAMA. 45,000+ participants across 68 countries, primarily women aged 35 to 60 with documented weight-loss resistance.
The finding wasn't about diet. It was neurological. In women who'd experienced pregnancy, estrogen decline, or chronic stress, the brain's satiety circuit had lost sensitivity to the body's own fullness signals. The hypothalamus, the brain structure that receives the "stop eating" message, was getting it too late, or not responding to it at all.
The practical effect: the brain keeps generating hunger signals, and cravings, independent of caloric intake. That persistent food preoccupation isn't a personality trait. It's what happens when a feedback loop breaks.
"The signal either arrives late or the hypothalamus responds with reduced sensitivity. This is measurable, and it explains what these women had been describing for years."
— STEP Trial Summary · New England Journal of Medicine · 2021
What they were prescribed
The study used GLP-1 receptor agonists, compounds that mimic the satiety hormone whose signal had stopped reaching the brain. Two versions were studied.
| Medication | Avg. weight loss | 20%+ outcomes | Method |
|---|
| Semaglutide | −15.3% | 22% of group | Weekly injection or oral |
| Tirzepatide (best outcomes) | −22.5% | 32% of group | Weekly injection |
| Diet and exercise only | −2.4% | 2% of group | — |
Tirzepatide activates two receptors, GLP-1 and GIP, producing a stronger satiety effect. In women with hormone-driven resistance, this was measurably more effective than semaglutide alone.
The protocol, best-outcome group
FOUR HABITS · CONSISTENTLY
01
Weekly clinician-prescribed GLP-1 injection, dose-adjusted every four weeks by a licensed physician.
02
30 to 40g protein at every meal. Not calorie restriction, just enough to preserve lean mass while weight drops. The study found this was the single most effective dietary change.
03
A 30-minute walk every day. The most consistent habit among those who maintained results after the study ended, because it asks nothing heroic.
04
Physician check-ins every four to eight weeks. Dose adjustments based on response. Built into the programme.
Clinician-prescribed GLP-1 treatment available through TrimRx. Free check, no payment required.
START FREE CHECK →
The clinical picture
ASSESSMENT
If you've put in consistent effort and the scale hasn't responded for years, the STEP data points to biology, not behaviour. GLP-1 medications are the only intervention shown to address this mechanism directly. The outcomes reported are averages, not outliers. A 160-pound woman averaged 24 pounds lost at six months.
How the cost changed
Brand-name GLP-1 medications cost over $1,000 a month without insurance. TrimRx works with FDA-registered compounding pharmacies to provide the same active compounds, clinician-prescribed, pharmaceutical standards, free delivery.
Brand-name retail
$1,300+
Per month, no insurance
TrimRx programme
✓
Clinician-prescribed · FDA-reg. pharmacy
Same active compounds. Doctor-supervised. Shipped to your door. The medication is the same. The price is different.
FREE ASSESSMENT
Start the free TrimRx eligibility check
If your profile matches the study, prior diet resistance, hormonal shifts, biological hunger, you likely qualify. A licensed clinician reviews every submission.
Same active compounds
Clinician-prescribed
FDA-registered pharmacy
Free delivery
No insurance needed
Cancel anytime
START FREE ELIGIBILITY CHECK →
NO PAYMENT AT ASSESSMENT · PHYSICIAN-REVIEWED · US RESIDENTS ONLY
Disclosure: sponsored content in partnership with TrimRx. Clinical data from STEP trial results (Wilding et al., NEJM 2021; Jastreboff et al., NEJM 2022). Average outcomes do not guarantee individual results. Compounded medications are not FDA-approved as finished drug products. Programme requires physician oversight. Individual results vary.
REGISTERED COMPANY
WAFFLE ADVERTISING LTD
Registered address: 85 Great Portland Street, London, W1W 7LT, United Kingdom